The CYP450 hydroxylase pathway contributes to P2X receptor-mediated afferent arteriolar vasoconstriction

Xueying Zhao, Edward W. Inscho, Muralidhar Bondlela, John R. Falck, John D. Imig

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

This study was conducted to test the hypothesis that the cytochrome P-450 (CYP450) metabolite 20-hydroxyeicosatetraenoic acid (20-HETE) contributes to the afferent arteriolar response to P2 receptor activation. Afferent arteriolar responses to ATP, the P2X agonist, α,β-methylene ATP and the P2Y agonist UTP were determined before and after treatment with the selective CYP450 hydroxylase inhibitor, N-methylsulfonyl-12,12-dibromododec-11-enamide (DDMS) or the 20-HETE antagonist, 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid (20-HEDE). Stimulation with 1.0 and 10 μM ATP elicited an initial preglomerular vasoconstriction of 12 ± 1% and 45 ± 4% and a sustained vasoconstriction of 11 ± 1% and 11 ± 2%, respectively. DDMS or 20-HEDE significantly attenuated the sustained afferent arteriolar constrictor response to ATP. α,β-Methylene ATP (1 μM) induced a rapid initial afferent vasoconstriction of 64 ± 3%, which partially recovered to a stable diameter 10 ± 1% smaller than control. Both DDMS and 20-HEDE significantly attenuated the initial vasoconstriction and abolished the sustained vasoconstrictor response to α,β-methylene ATP. UTP decreased afferent diameter by 50 ± 5% and 20-HEDE did not change this response. In addition, the ATP-induced increase in the intracellular Ca2+ concentration in preglomerular microvascular smooth muscle cells was significantly attenuated by 20-HEDE. Taken together, these results are consistent with the hypothesis that the CYP450 metabolite 20-HETE participates in the afferent arteriolar response to activation of P2X receptors.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume281
Issue number5 50-5
StatePublished - 2001

Fingerprint

Mixed Function Oxygenases
Vasoconstriction
Cytochrome P-450 Enzyme System
Adenosine Triphosphate
Uridine Triphosphate
Vasoconstrictor Agents
Smooth Muscle Myocytes
20-hydroxyeicosa-6(Z),15(Z)-dienoic acid
DDMS
20-hydroxy-5,8,11,14-eicosatetraenoic acid

Keywords

  • α,β-methylene adenosine trisphosphate
  • 20-hydroxyeicosatetraenoic acid
  • Afferent arterioles
  • ATP
  • Renal microcirculation
  • UTP

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

The CYP450 hydroxylase pathway contributes to P2X receptor-mediated afferent arteriolar vasoconstriction. / Zhao, Xueying; Inscho, Edward W.; Bondlela, Muralidhar; Falck, John R.; Imig, John D.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 281, No. 5 50-5, 2001.

Research output: Contribution to journalArticle

@article{0f10d20efef24807be6fcada0d0c1898,
title = "The CYP450 hydroxylase pathway contributes to P2X receptor-mediated afferent arteriolar vasoconstriction",
abstract = "This study was conducted to test the hypothesis that the cytochrome P-450 (CYP450) metabolite 20-hydroxyeicosatetraenoic acid (20-HETE) contributes to the afferent arteriolar response to P2 receptor activation. Afferent arteriolar responses to ATP, the P2X agonist, α,β-methylene ATP and the P2Y agonist UTP were determined before and after treatment with the selective CYP450 hydroxylase inhibitor, N-methylsulfonyl-12,12-dibromododec-11-enamide (DDMS) or the 20-HETE antagonist, 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid (20-HEDE). Stimulation with 1.0 and 10 μM ATP elicited an initial preglomerular vasoconstriction of 12 ± 1{\%} and 45 ± 4{\%} and a sustained vasoconstriction of 11 ± 1{\%} and 11 ± 2{\%}, respectively. DDMS or 20-HEDE significantly attenuated the sustained afferent arteriolar constrictor response to ATP. α,β-Methylene ATP (1 μM) induced a rapid initial afferent vasoconstriction of 64 ± 3{\%}, which partially recovered to a stable diameter 10 ± 1{\%} smaller than control. Both DDMS and 20-HEDE significantly attenuated the initial vasoconstriction and abolished the sustained vasoconstrictor response to α,β-methylene ATP. UTP decreased afferent diameter by 50 ± 5{\%} and 20-HEDE did not change this response. In addition, the ATP-induced increase in the intracellular Ca2+ concentration in preglomerular microvascular smooth muscle cells was significantly attenuated by 20-HEDE. Taken together, these results are consistent with the hypothesis that the CYP450 metabolite 20-HETE participates in the afferent arteriolar response to activation of P2X receptors.",
keywords = "α,β-methylene adenosine trisphosphate, 20-hydroxyeicosatetraenoic acid, Afferent arterioles, ATP, Renal microcirculation, UTP",
author = "Xueying Zhao and Inscho, {Edward W.} and Muralidhar Bondlela and Falck, {John R.} and Imig, {John D.}",
year = "2001",
language = "English (US)",
volume = "281",
journal = "American Journal of Physiology - Heart and Circulatory Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "5 50-5",

}

TY - JOUR

T1 - The CYP450 hydroxylase pathway contributes to P2X receptor-mediated afferent arteriolar vasoconstriction

AU - Zhao, Xueying

AU - Inscho, Edward W.

AU - Bondlela, Muralidhar

AU - Falck, John R.

AU - Imig, John D.

PY - 2001

Y1 - 2001

N2 - This study was conducted to test the hypothesis that the cytochrome P-450 (CYP450) metabolite 20-hydroxyeicosatetraenoic acid (20-HETE) contributes to the afferent arteriolar response to P2 receptor activation. Afferent arteriolar responses to ATP, the P2X agonist, α,β-methylene ATP and the P2Y agonist UTP were determined before and after treatment with the selective CYP450 hydroxylase inhibitor, N-methylsulfonyl-12,12-dibromododec-11-enamide (DDMS) or the 20-HETE antagonist, 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid (20-HEDE). Stimulation with 1.0 and 10 μM ATP elicited an initial preglomerular vasoconstriction of 12 ± 1% and 45 ± 4% and a sustained vasoconstriction of 11 ± 1% and 11 ± 2%, respectively. DDMS or 20-HEDE significantly attenuated the sustained afferent arteriolar constrictor response to ATP. α,β-Methylene ATP (1 μM) induced a rapid initial afferent vasoconstriction of 64 ± 3%, which partially recovered to a stable diameter 10 ± 1% smaller than control. Both DDMS and 20-HEDE significantly attenuated the initial vasoconstriction and abolished the sustained vasoconstrictor response to α,β-methylene ATP. UTP decreased afferent diameter by 50 ± 5% and 20-HEDE did not change this response. In addition, the ATP-induced increase in the intracellular Ca2+ concentration in preglomerular microvascular smooth muscle cells was significantly attenuated by 20-HEDE. Taken together, these results are consistent with the hypothesis that the CYP450 metabolite 20-HETE participates in the afferent arteriolar response to activation of P2X receptors.

AB - This study was conducted to test the hypothesis that the cytochrome P-450 (CYP450) metabolite 20-hydroxyeicosatetraenoic acid (20-HETE) contributes to the afferent arteriolar response to P2 receptor activation. Afferent arteriolar responses to ATP, the P2X agonist, α,β-methylene ATP and the P2Y agonist UTP were determined before and after treatment with the selective CYP450 hydroxylase inhibitor, N-methylsulfonyl-12,12-dibromododec-11-enamide (DDMS) or the 20-HETE antagonist, 20-hydroxyeicosa-6(Z),15(Z)-dienoic acid (20-HEDE). Stimulation with 1.0 and 10 μM ATP elicited an initial preglomerular vasoconstriction of 12 ± 1% and 45 ± 4% and a sustained vasoconstriction of 11 ± 1% and 11 ± 2%, respectively. DDMS or 20-HEDE significantly attenuated the sustained afferent arteriolar constrictor response to ATP. α,β-Methylene ATP (1 μM) induced a rapid initial afferent vasoconstriction of 64 ± 3%, which partially recovered to a stable diameter 10 ± 1% smaller than control. Both DDMS and 20-HEDE significantly attenuated the initial vasoconstriction and abolished the sustained vasoconstrictor response to α,β-methylene ATP. UTP decreased afferent diameter by 50 ± 5% and 20-HEDE did not change this response. In addition, the ATP-induced increase in the intracellular Ca2+ concentration in preglomerular microvascular smooth muscle cells was significantly attenuated by 20-HEDE. Taken together, these results are consistent with the hypothesis that the CYP450 metabolite 20-HETE participates in the afferent arteriolar response to activation of P2X receptors.

KW - α,β-methylene adenosine trisphosphate

KW - 20-hydroxyeicosatetraenoic acid

KW - Afferent arterioles

KW - ATP

KW - Renal microcirculation

KW - UTP

UR - http://www.scopus.com/inward/record.url?scp=0035203299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035203299&partnerID=8YFLogxK

M3 - Article

C2 - 11668070

AN - SCOPUS:0035203299

VL - 281

JO - American Journal of Physiology - Heart and Circulatory Physiology

JF - American Journal of Physiology - Heart and Circulatory Physiology

SN - 0363-6135

IS - 5 50-5

ER -